More PRNewswire
View Older Stories View Newer Stories-
TREMFYA® (guselkumab) demonstrates superiority versus STELARA® (ustekinumab) in Phase 3 Crohn's disease program
-
Calm Tech Institute Launches To Help Humanize Product Design
-
CAGC Welcomes Member Engagement Manager
-
Docufree's Digital Mailroom Wins Bronze Stevie Award in 2024 American Business Awards
-
Empowering fleets through data: Geotab and Rivian partner to deliver integrated telematics solution
-
Braille Institute Announces 2024 Teacher of the Year Lauren Ingersoll
-
New Harris Poll Finds 'Summer Swaps' Expected to Continue Due to Current Economic Climate
-
Sapiens to Participate in Upcoming Investor Conferences
-
ResMan Hosts Third Annual Customer Conference, ResMania
-
Rust-Oleum Selects Arm Candy as Agency of Record for All Brands
-
Foxit and NotaryLive Announce Strategic Partnership to Seamlessly Integrate Notary Services Into the Foxit Platform
-
Quobly Names its Scientific Advisory Board
-
PepsiCo Announces Timing and Availability of Second-Quarter 2024 Financial Results
-
BigONE Boosts TOKEN2049 Dubai Edition, Launches Major Side Event
-
Letter From Center for Competitive Democracy (CCD) Blasts CNN's Planned Biden-Trump Debate as 'Sham' on Public That Would Violate Campaign Finance Law
-
Radware is the Leader in the 2024 SPARK Matrix™ for DDoS Mitigation by Quadrant Knowledge Solutions
-
ImmPACT Bio to Present New Preclinical Data for CD19/CD20 Bispecific CAR-T Cell Therapy in Multiple Sclerosis
-
Get More From Your Credit Cards with CardRight's Personal Finance App
-
UniDoc H3 Cube Designated as the Preferred Equipment for eHealth by Italian Government
-
LEGGETT & PLATT APPOINTS KARL GLASSMAN AS PRESIDENT AND CEO
-
Euldora Financial Acquires Wallner Media Group, Appoints Jeff Wallner as President of Production and Board Member
-
SuVax™ and MarVax™ Thermostable Vaccine Platform to be Presented at the Vaccine Technology IX Conference
-
Eltek Ltd. Reports 2024 First Quarter Financial Results
-
Anixa Biosciences Commences Treatment of Fifth Patient in Ovarian Cancer CAR-T Clinical Trial
-
ColoTest for Colon Cancer Screening Now Available at Select Walmart Locations
-
Outdoorsy Releases Generations in the Wild: The 2024 U.S. Family RV Travel Report
-
InteliChart Excels in KLAS First Look Spotlight Report with Superior Patient Portal Performance
-
Ascent Strategy Group, the first agency founded to fuel the Digital Health revolution, introduces the industry's first communications tools to guide healthcare's transformation
-
New Omdia research states that cellular IoT data traffic will comprise 4.2% of total cellular data traffic in 2028
-
VANTIS VASCULAR SECURES $5 MILLION IN SAFE FINANCING TO DRIVE INNOVATION IN VASCULAR INTERVENTIONS
-
Halozyme Announces Bristol Myers Squibb Received Updated Action Date from the U.S. Food and Drug Administration for Subcutaneous Nivolumab Co-Formulated with ENHANZE®
-
First Batch of Green Energy Buses with Yuchai Xingshunda Hydrogen Fuel Cells Launched
-
Introducing the Bridge: Flair's New Dedicated Plug-and-Play Networking Gateway
-
OneOncology's Treatment Pathways Certified by ASCO
-
Treasure Island Resort & Casino Hosts Minnesota Timberwolves Playoff Watch Parties Featuring Local Media Personalities and Playoff Ticket Giveaways
-
Lam Research Corporation Announces $10 Billion Share Repurchase Authorization and a 10-for-1 Stock Split
-
Now Open: U-Haul of Germantown Serving Customers at Former K-Mart Site
-
Eir Partners Closes Oversubscribed $496 Million Investment Program II
-
Casterra Announces Additional Agreements with Seed Producers to Meet Existing & Growing Demand for its Elite Castor Seeds
-
ActiveDraft Bridges the Gap in Construction Document Collaboration with Game-changing ActiveLink Technology
-
Ripley PR named one of Newsweek's Top PR Agencies for 2024
-
OneConnect Announces First Quarter 2024 Unaudited Financial Results
-
Full Truck Alliance Co. Ltd. Announces First Quarter 2024 Unaudited Financial Results
-
Telycam to Kick Off 10-Year Anniversary Celebrations at InfoComm 2024
-
Citius Pharmaceuticals Achieves Primary and Secondary Endpoints in Phase 3 Trial of Mino-Lok Antibiotic Lock Solution
-
ZIM Reports Financial Results for the First Quarter of 2024; Raising Full Year 2024 Guidance
-
Drilling Dramatically Increases Strike Length of D-Vein with highs to 920 gpt Silver and 4.1% lead-zinc at Columba High-Grade Silver Project
-
LucyRx's Growth Accelerates through Strategic Investments
-
New Study Reveals Pycnogenol® Inhibits Skin Discoloration After Spider Vein Treatment
-
Nearmap Appoints Ray Savona as Chief Revenue Officer
